Another UK Biotech Snapped Up As Neurocrine Buys Diurnal

US Firm Paying Just £48m

 
• By Kevin Grogan
  
A pair of feet standing on a tarmac road with yellow arrow print pointing in three different directions for the concept of making decision at the crossroad.
Diurnal plumps for the takeover route • Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business